FDA authorizes remdesivir as emergency treatment for COVID-19
The FDA has granted authorization to Gilead Sciences for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook